Patlytics Stock
| Valuation | $311.89M1 |
| Valuation Date | Apr 8, 2026 |
| Implied Valuation | n/a |
| Last Price | n/a |
| 52-Week High | n/a |
| 52-Week Low | n/a |
| YTD Return | n/a |
| 1-Year Return | n/a |
| 3-Year Return | n/a |
| Total Funding | $65M2 |
| Latest Round Amount | $40M2 |
| Latest Round | Series B |
| Funding Rounds | 3 |
| IPO Status | Unknown |
| Expected IPO Date | n/a |
| Revenue | n/a |
| Revenue Type | n/a |
| P/S Ratio | n/a |
About Patlytics
Patlytics is an AI software company that builds a platform for patent work. Its tools cover the full patent lifecycle, from invention disclosure and application drafting to prosecution, infringement analysis, invalidity research and portfolio management. The platform is used by patent attorneys at large law firms and by corporate IP teams. The company says over 40% of the Am Law 100 firms are customers. Patlytics makes money by selling subscriptions to its software. It was co-founded by Paul Lee, a former venture capitalist, and Arthur Jen, who previously co-founded the crypto wallet company Magic.
Invest in Patlytics
Patlytics is a private company, so you can't purchase it with a regular brokerage account. However, the company is listed on Forge.
Forge is a trusted platform for transactions of shares of private companies. It is a subsidiary of The Charles Schwab Corporation.
Invest on ForgeDisclosure: Stock Analysis may be compensated for user sign-ups through Forge links.
Related Companies
News
Patlytics raises $40M Series B to expand AI platform for IP work
SignalFire led a $40 million Series B bringing total funding to about $65 million, as Patlytics reports nearly 1,000% year-over-year revenue growth and adoption by over 40% of the Am Law 100.
Patlytics Raises $40 Million Series B to Expand the AI Platform Purpose-Built for IP Work
Patlytics raised $40 million in a Series B on April 8, 2026 led by SignalFire, bringing total funding to about $65 million for its AI platform covering the full patent lifecycle.
.png)
The Patent Platform Built for What the Work Actually Demands
Patlytics said the April 2026 Series B will fund collaboration tools, autonomous IP agents, and chem-bio patent capabilities as it serves more than 40% of Am Law 100 IP practices.